Content Provided by Zacks.com
Analyst Blog  

CHINA Poised for More Growth

January 05, 2009 | Comments: 0
Recommended this article (1)

After beginning life as a pan-Asian integrated Internet company, CDC Corporation (CHINA - Snapshot Report) changed its name to chinadotcom corporation in 2000 to provide a proper identity to the company. It then changed its name to CDC Corporation in 2005 to better reflect the company's development into a larger and more diverse enterprise.

Ever since its inception as an Internet pioneer in Asia, the company has grown and evolved into a global provider of enterprise software, online games, business solutions, mobile and Internet applications.

With a strong track record in consolidation and organic growth of its software business, we believe CDC is poised for growth. With continuous focus on vertical industries and cost reduction initiatives in its software segment, CDC should develop a significant competitive advantage in 2009 and beyond.

New launches and upgrades (Yulgang 2.0 and Ross Enterprise v6.3) in its product line as well as its share repurchase plan currently in action will further help the company drive growth. As such, we maintain our Buy rating on the shares of CDC with a six-month target price of $3.50.

Priyanka Poddar contributed to this report.

Read the full analyst report on CHINA